BIOLINERX LTD's ticker is BLRXXXXX and the CUSIP is 09071M106. A total of 27 filers reported holding BIOLINERX LTD in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $9,488,000 | -15.1% | 25,995,575 | 0.0% | 1.04% | -17.3% |
| Q1 2019 | $11,178,000 | -1.7% | 25,995,575 | 0.0% | 1.25% | -15.7% |
| Q4 2018 | $11,368,000 | -59.1% | 25,995,575 | 0.0% | 1.49% | -39.2% |
| Q3 2018 | $27,815,000 | +18.3% | 25,995,575 | 0.0% | 2.44% | +6.4% |
| Q2 2018 | $23,521,000 | +4.0% | 25,995,575 | 0.0% | 2.30% | +0.1% |
| Q1 2018 | $22,616,000 | -20.2% | 25,995,575 | 0.0% | 2.29% | -32.9% |
| Q4 2017 | $28,335,000 | -2.7% | 25,995,575 | 0.0% | 3.42% | -7.7% |
| Q3 2017 | $29,115,000 | +95.7% | 25,995,575 | +48.5% | 3.70% | +60.2% |
| Q2 2017 | $14,875,000 | -11.5% | 17,500,000 | 0.0% | 2.31% | -19.2% |
| Q1 2017 | $16,809,000 | +430.8% | 17,500,000 | +1065.9% | 2.86% | +331.9% |
| Q1 2015 | $3,167,000 | +30.2% | 1,501,000 | 0.0% | 0.66% | +40.0% |
| Q4 2014 | $2,432,000 | +5.2% | 1,501,000 | 0.0% | 0.47% | -1.5% |
| Q3 2014 | $2,312,000 | -25.9% | 1,501,000 | 0.0% | 0.48% | -2.8% |
| Q2 2014 | $3,122,000 | +75.0% | 1,501,000 | +87.6% | 0.49% | +78.3% |
| Q1 2014 | $1,784,000 | – | 800,000 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Senvest Management, LLC | 3,543,300 | $2,835,000 | 0.23% |
| Opaleye Management Inc. | 250,000 | $223,000 | 0.15% |
| Benchmark Capital Advisors | 44,000 | $35,000 | 0.03% |
| MENTA CAPITAL LLC | 98,647 | $79,000 | 0.01% |
| NEXT Financial Group, Inc | 39,500 | $31,000 | 0.01% |
| Cutter & CO Brokerage, Inc. | 25,000 | $20,000 | 0.01% |
| Orbimed Advisors | 1,038,600 | $831,000 | 0.01% |
| TWO SIGMA SECURITIES, LLC | 17,771 | $14,000 | 0.01% |
| Alyeska Investment Group, L.P. | 611,947 | $490,000 | 0.01% |
| A.R.T. Advisors, LLC | 25,890 | $20,000 | 0.00% |